The new bedside monitoring system continuously measures heart rate, breath rate and motion without requiring patient contact, according to the release. Constantly monitoring vitals and receiving reports of vital trends can help reduce the potential for an adverse event, according to the release.
More Articles on the FDA:
FDA Clears Smiths Medical to Market Patient-Controlled Pain
FDA Approves Gore Medical’s Viabhan Endoprosthesis Devices Use Expansion
FDA, European Medicines Agency to Collaborate on Generic Drug Approvals
Next Up in Supply Chain
-
Becker’s asked supply chain leaders: What’s the most productive partnership supply chain has with another department at your system, and…
-
Medline is laying off 304 workers, according to a notice filed with the state of Illinois and a Nov. 5…
-
As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
